| 000 | 01108 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511231543.0 | ||
| 264 | 0 | _c19910116 | |
| 008 | 199101s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.301.6760.1103-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCruickshank, D J | |
| 245 | 0 | 0 |
_aAtenolol in essential hypertension during pregnancy. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cNov 1990 |
||
| 300 |
_a1103 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comment; Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAtenolol _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetal Growth Retardation _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aLabetalol _xadverse effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Cardiovascular _xdrug therapy |
| 700 | 1 | _aCampbell, D M | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 301 _gno. 6760 _gp. 1103 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.301.6760.1103-b _zAvailable from publisher's website |
| 999 |
_c2255171 _d2255171 |
||